Eilon S. Amir is the Vice President at Outcome Capital and brings a unique combination of strategic and transactional expertise with over 15 years of experience in corporate strategy and finance, merger and acquisitions and business development in innovative life sciences companies.
Prior to joining Outcome Capital, Mr. Amir was the Director of Business Development/M&A at Merck/EMD Millipore where he worked on divisional transactions in collaboration with the Corporate Group M&A and Business Units. Prior to Merck/EMD Millipore, Mr. Amir was the Director of Corporate Development/M&A at Perkin Elmer where he was responsible for executing M&A and business development strategies for life science tools, analytics, and diagnostics.
Mr. Amir also held several positions in the investment banking industry including Senior Associate at Citigroup Corporate Finance/ Investment Banking focusing on technology companies and Associate at American Capital pursuing leveraged buyouts and private equity investments. Prior to American Capital, Mr. Amir spent four years with the Merchant Banking and Commercial Finance Group at GE Capital. While at GE Capital, Mr. Eilon also participated in a joint venture between GE Capital and The Goldman Sachs Group, Inc.
He received his BA in finance and Marketing from University of Wisconsin-Madison and Executive MBA degree from the Hebrew University in Jerusalem